首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Sufentanil-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex For Pain Treatment: Characterization,Toxicity and Pharmacological Evaluation
【24h】

Sufentanil-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex For Pain Treatment: Characterization,Toxicity and Pharmacological Evaluation

机译:舒芬太尼-2-羟丙基-β-环糊精包合物用于疼痛治疗:表征,毒性和药理评价

获取原文

摘要

This study aimed to characterize and to investigate thehemolytic effects, the miotoxicity and the analgesicproperties of the sufentanil:2-hydroxypropyl-β-cyclodextrin inclusion complex (SUF:HP-β-CD).Physico-chemical characterization indicated the formationof a stable complex. In vitro and in vivo assays showedthat the SUF:HP-β-CD presented muscle compatibility,less hemolytic effects and increased the duration ofanalgesia, being an effective novel formulation to enhancethe pharmacological effects of sufentanil.
机译:这项研究旨在表征和调查 溶血作用,微毒性和止痛药 芬太尼的性质:2-羟丙基-β- 环糊精包合物(SUF:HP-β-CD)。 物化特征表明形成 一个稳定的复合体。体外和体内测定显示 SUF:HP-β-CD具有肌肉相容性, 溶血作用较小,持续时间更长 镇痛,是一种有效的新型配方,可以增强 舒芬太尼的药理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号